Home » Topics » Regulatory

Regulatory
RSS

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

ProCyte's hair transplant wound dressing approved by FDA

March 17, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

First approval for naratriptan

March 12, 1997

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

RAS inhibitors reduce mortality in a model of cerebral ischemia

March 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.